Literature DB >> 30346398

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome.

Ping Xue1, Zhiqiang Wang1, Xiaomin Fu2, Junjiang Wang3, Gopika Punchhi1, Andrew Wolfe4, Sheng Wu5.   

Abstract

Hyperandrogenemia plays a critical role in reproductive and metabolic function in females and is the hallmark of polycystic ovary syndrome. Developing a lean PCOS-like mouse model that mimics women with PCOS is clinically meaningful. In this protocol, we describe such a model. By inserting a 4 mm length of DHT (dihydrotestosterone) crystal powder pellet (total length of pellet is 8 mm), and replacing it monthly, we are able to produce a PCOS-like mouse model with serum DHT levels 2 fold higher than mice not implanted with DHT (no-DHT). We observed reproductive and metabolic dysfunction without changing body weight and body composition. While exhibiting a high degree of infertility, a small subset of these PCOS-like female mice can get pregnant and their offspring show delayed puberty and increased testosterone as adults. This PCOS-like lean mouse model is a useful tool to study the pathophysiology of PCOS and the offspring from these PCOS-like dams.

Entities:  

Mesh:

Year:  2018        PMID: 30346398      PMCID: PMC6235414          DOI: 10.3791/58379

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  33 in total

1.  Female Offspring From Chronic Hyperandrogenemic Dams Exhibit Delayed Puberty and Impaired Ovarian Reserve.

Authors:  Zhiqiang Wang; Mingjie Shen; Ping Xue; Sara A DiVall; James Segars; Sheng Wu
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

Review 2.  Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.

Authors:  Rodolfo C Cardoso; Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Neuroendocrinology       Date:  2015-04-01       Impact factor: 4.914

3.  Androgen Receptor in the Ovary Theca Cells Plays a Critical Role in Androgen-Induced Reproductive Dysfunction.

Authors:  Yaping Ma; Stanley Andrisse; Yi Chen; Shameka Childress; Ping Xue; Zhiqiang Wang; Dustin Jones; CheMyong Ko; Sara Divall; Sheng Wu
Journal:  Endocrinology       Date:  2017-01-01       Impact factor: 4.736

4.  Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort.

Authors:  Marlieke A de Wilde; Jacobien B Eising; Marlise N Gunning; Maria P H Koster; Annemieke M V Evelein; Geertje W Dalmeijer; Cuno S P M Uiterwaal; Marinus J C Eijkemans; Cornelis K van der Ent; Folkert J Meijboom; Bart C J M Fauser
Journal:  Reprod Sci       Date:  2018-01-10       Impact factor: 3.060

5.  Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome.

Authors:  Alice Pierre; Joëlle Taieb; Frank Giton; Michaël Grynberg; Salma Touleimat; Hady El Hachem; Renato Fanchin; Danielle Monniaux; Joëlle Cohen-Tannoudji; Nathalie di Clemente; Chrystèle Racine
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

6.  A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.

Authors:  Alexander S Kauffman; Varykina G Thackray; Genevieve E Ryan; Kristen P Tolson; Christine A Glidewell-Kenney; Sheila J Semaan; Matthew C Poling; Nahoko Iwata; Kellie M Breen; Antoni J Duleba; Elisabet Stener-Victorin; Shunichi Shimasaki; Nicholas J Webster; Pamela L Mellon
Journal:  Biol Reprod       Date:  2015-07-22       Impact factor: 4.285

7.  Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.

Authors:  A S L Caldwell; L J Middleton; M Jimenez; R Desai; A C McMahon; C M Allan; D J Handelsman; K A Walters
Journal:  Endocrinology       Date:  2014-05-30       Impact factor: 4.736

Review 8.  Polycystic ovary syndrome and its developmental origins.

Authors:  Daniel A Dumesic; David H Abbott; Vasantha Padmanabhan
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

9.  The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.

Authors:  Ebru Dikensoy; Ozcan Balat; Sadrettin Pence; Cenk Akcali; Hulya Cicek
Journal:  Arch Gynecol Obstet       Date:  2008-07-08       Impact factor: 2.344

10.  The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome.

Authors:  Scott T Kelley; Danalea V Skarra; Alissa J Rivera; Varykina G Thackray
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more
  5 in total

Review 1.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

2.  Gonadotrope androgen receptor mediates pituitary responsiveness to hormones and androgen-induced subfertility.

Authors:  Zhiqiang Wang; Mingxiao Feng; Olubusayo Awe; Yaping Ma; Mingjie Shen; Ping Xue; Rexford Ahima; Andrew Wolfe; James Segars; Sheng Wu
Journal:  JCI Insight       Date:  2019-08-08

3.  Androgen-induced insulin resistance is ameliorated by deletion of hepatic androgen receptor in females.

Authors:  Stanley Andrisse; Mingxiao Feng; Zhiqiang Wang; Olubusayo Awe; Lexiang Yu; Haiying Zhang; Sheng Bi; Hongbing Wang; Linhao Li; Serene Joseph; Nicola Heller; Franck Mauvais-Jarvis; Guang William Wong; James Segars; Andrew Wolfe; Sara Divall; Rexford Ahima; Sheng Wu
Journal:  FASEB J       Date:  2021-10       Impact factor: 5.834

4.  Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor.

Authors:  Mingxiao Feng; Sara Divall; Dustin Jones; Vaibhave Ubba; Xiaomin Fu; Ling Yang; Hong Wang; Xiaofeng Yang; Sheng Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

5.  Prenatal androgen exposure causes a sexually dimorphic transgenerational increase in offspring susceptibility to anxiety disorders.

Authors:  Sanjiv Risal; Maria Manti; Haojiang Lu; Romina Fornes; Henrik Larsson; Anna Benrick; Qiaolin Deng; Carolyn E Cesta; Mina A Rosenqvist; Elisabet Stener-Victorin
Journal:  Transl Psychiatry       Date:  2021-01-13       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.